MATINAS BIOPHARMA HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $668.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- MATINAS BIOPHARMA HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $668.00K, a 0.00% change from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $668.00K, a 89.61% decline from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $6.43M, a 91.00% increase from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $3.37M, a 41.98% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $668.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $668.00K 10-K · filed 2026-03-31 | $5.43M 10-K · filed 2025-04-15 |
| 2023-12-31 | $6.43M 10-K · filed 2025-04-15 | |
| 2022-12-31 | $3.37M 10-K · filed 2024-03-27 | $3.40M 10-K · filed 2023-03-15 |
| 2021-12-31 | $5.80M 10-K · filed 2023-03-15 | |
| 2020-12-31 | $5.50M 10-K/A · filed 2022-03-11 | |
| 2019-12-31 | $5.20M 10-K · filed 2020-03-09 | |
| 2018-12-31 | $3.90M 10-K · filed 2019-04-01 | |
| 2017-12-31 | $200.00K 10-K · filed 2018-03-16 | |
| 2016-12-31 | $2.40M 10-K · filed 2017-03-31 | |
| 2015-12-31 | $3.10M 10-K · filed 2016-03-30 | |
| 2014-12-31 | $3.70M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |